Announcements Trials
Browse Landscape

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 142Observational 5

Sponsor

Cancer Type

Plasma cell 5Genitourinary 2

Conditions

Multiple Myeloma 5Acute Kidney Injury 2

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Observational × daratumumab × Clear all
NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

Brigham and Women's Hospital

Completed
20 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT06483139 2025-11-19

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Brigham and Women's Hospital

Recruiting
450 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT05835726 2025-08-15

DILEMMA

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
188 enrolled
Plasma cell

Multiple Myeloma

NCT05306587 2024-04-03

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

Odense University Hospital

Completed
40 enrolled
Plasma cell

Multiple Myeloma

NCT05218603 2022-09-16

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

PETHEMA Foundation

Unknown
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡